Citations

Showing 10 of 108094 citations.

Neutrophil to lymphocyte ratio: lack of association with sentinel lymph node biopsy status and relapse‐free survival in cutaneous melanoma patients
Meves, Elena S., Meves, Alexander

Mayo Clinic

International Journal of Dermatology | August 12, 2022 | Volume: 62 | Issue: 6 | Pages: No page available

10.1111/ijd.16396 | PMID 35959518 Get It

Epidemiology and Financial Burden of Adult Chronic Hypoparathyroidism
Björnsdóttir, Sigríður , Ing, Steven , Mitchell, Deborah M. , Sikjær, Tanja , Underbjerg, Line , Hassan‐Smith, Zaki , Sfeir, Jad , Gittoes, Neil , Clarke, B.L. , Gittoes, Neil J , Clarke, Bart L , Sfeir, Jad G

Mayo Clinic

Journal of Bone and Mineral Research | August 12, 2022 | Volume: 37 | Issue: 12 | Pages: 2602-2614

10.1002/jbmr.4675 | PMID 36054571 Get It

ABSTRACT Chronic hypoparathyroidism is characterized by low serum calcium, increased serum phosphorus, and inappropriately low or decreased serum parathyroid hormone. This rare disorder is associated with a variety of complications. The prevalence, incidence, mortality, financial burden, and epidemiology of complications of this disorder are not well understood. This narrative review summarizes current information on the epidemiology and complications of chronic hypoparathyroidism. The reported prevalence of chronic hypoparathyroidism ranges from 6.4–37/100,000, and the incidence is reported to be 0.8–2.3/100,000/year. Mortality is not increased in studies from Denmark or South Korea but was increased in studies from Scotland and Sweden. The financial burden of this disorder is substantial because of increased health care resource utilization in two studies but not well quantitated. Recognized complications include hypercalciuria, nephrocalcinosis, kidney stones, and chronic kidney disease; low bone turnover and possibly upper extremity fractures; cardiac and vascular calcifications; basal ganglia calcifications, cataracts, infections, neuropsychiatric complications, and difficulties with pregnancy. This review concludes that chronic hypoparathyroidism is a rare disorder associated with significant morbidity that may not increase overall mortality but is associated with a substantial financial burden. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
Historical Changes in Weight Classes and the Influence of NAFLD Prevalence: A Population Analysis of 34,486 Individuals
Nah, Benjamin , Tan, Caitlyn , Aggarwal, Manik , Zeng, Rebecca Wenling , Xiao, Jieling , Tan, Eunice Xiang‐Xuan, Ren, Yi Ping , Chee, Douglas , Neo, Jonathan W. H., Chew, Nicholas , Tseng, Michael T. , Siddiqui, Mohammad Shadab , Dan, Yock Young , Tan, Eunice X. , Ng, Cheng Han , Tan, Caitlyn , Aggarwal, Manik , Chew, Nicholas W S , Tseng, Michael , Ng, Cheng Han , Chan, Kai En , Chin, Yip Han , Tan, Eunice Xiang Xuan , Neo, Jonathan, Sanyal, Arun J. , Muthiah, Mark D

Mayo Clinic

International Journal of Environmental Research and Public Health | August 11, 2022 | Volume: 19 | Issue: 16 | Pages: 9935

10.3390/ijerph19169935 | PMID 36011567 Get It

Background: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease globally in tandem with the growing obesity epidemic. However, there is a lack of data on the relationship between historical weight changes 10 years ago and at present on NAFLD prevalence at the population level. Therefore, we sought to evaluate the relationship between weight classes and the prevalence of NAFLD. Methods: Data were used from the United States National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018. Univariate and multivariate general linear model analyses were used to obtain risk ratio (RR) estimations of NAFLD events. Results: In total, 34,486 individuals were analysed, with those who were lean at both time points as the control group. Overweight (RR: 14.73, 95%CI: 11.94 to 18.18, p < 0.01) or obese (RR: 31.51, 95%CI: 25.30 to 39.25, p < 0.01) individuals at both timepoints were more likely to develop NAFLD. Residual risk exists where previously obese individuals became overweight (RR: 14.72, 95%CI: 12.36 to 17.52, p < 0.01) or lean (RR: 2.46, 95%CI: 1.40 to 4.31, p = 0.02), and previously overweight individuals who became lean (RR 2.24, 95%CI 1.42 to 3.54, p = 0.01) had persistent elevated risk of developing NAFLD despite weight regression. Sensitivity analysis identified that a higher proportion of individuals with regression in weight class were diabetics and Mexican Americans, while fewer African Americans saw weight-class regression. Conclusions: Residual risk exists in patients who lost weight despite the smaller magnitude of effect, and targeted weight reductions should still be used to mitigate the risk of NAFLD at the population level.
Endothelin-1 receptor blockade does not alter the sympathetic and hemodynamic response to acute intermittent hypoxia in men
Limberg, Jacqueline K. , Baker, Sarah E. , Ott, Elizabeth P., Jacob, Dain W. , Scruggs, Zachariah M., Harper, Jennifer L. , Manrique‐Acevedo, Camila , Manrique-Acevedo, Camila M , Baker, Sarah E

Mayo Clinic

Journal of Applied Physiology | August 11, 2022 | Volume: 133 | Issue: 4 | Pages: 867-875

10.1152/japplphysiol.00837.2021 | PMID 35952348 Get It

Repeat exposures to low oxygen (intermittent hypoxia, IH) elicit increases in muscle sympathetic nerve activity (MSNA) and blood pressure (BP) in men. Endothelin (ET) receptor antagonists can attenuate the sympathetic and BP response to IH in rodents; whether these data translate to humans were unclear. We show acute IH results in an increase in ET-1, MSNA, and BP in healthy young men; however, the effect of IH on MSNA and BP does not occur through activation of ET-receptors in healthy young men.
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial
Sinicrope, Frank A. , Shi, Qian , Catteau, Aurélie , Poage, Graham M. , Mlecnik, Bernhard , Benson, Al B. , Gill, Sharlene , Goldberg, Richard M. , Kahlenberg, Morton S., Nair, Suresh , Shields, Anthony F. , Smyrk, Thomas C. , Mlecnik, Bernhard , Benson, Al , Gill, Sharlene , Goldberg, Richard M , Nair, Suresh , Shields, Anthony F , Galon, Jerome , Alberts, Steven R , Sinicrope, Frank A , Shi, Qian , Zemla, Tyler , Galon, Jérôme , Alberts, Steven R.

Mayo Clinic

JCO Precision Oncology | August 11, 2022 | Volume: No volume available | Issue: 6 | Pages: No page available

10.1200/po.22.00010 | PMID 35952316 Get It

PURPOSE The recommended duration of adjuvant fluoropyrimidine and oxaliplatin chemotherapy for patients with stage III colon cancer is based on tumor classification into clinically low-risk (T1-3 N1) and high-risk (T4 or N2) groups. We determined whether Immunoscore can enhance prognostication within these risk groups. MATERIALS AND METHODS Patients with stage III colon carcinomas (N = 600) were randomly selected from the infusional fluorouracil, leucovorin, and oxaliplatin arm of adjuvant trial NCCTG N0147 (Alliance for Clinical Trials in Oncology). Tumors were evaluated for Immunoscore that quantifies CD3+ and CD8+ T-cell densities in the tumor center and invasive margin by digital image analysis. Disease-free survival (DFS) by Immunoscore was analyzed using a multivariable Cox regression model in each risk group with adjustment for covariates including KRAS, BRAF V600E, and mismatch repair status. RESULTS Of 559 cancers with Immunoscore data, 299 (53.5%) were classified as clinically low-risk (T1-3 N1) and 260 (46.5%) as clinically high-risk (T4 and/or N2). Among patients with low-risk tumors, those with Immunoscore-Low versus Immunoscore-High tumors had significantly worse 5-year DFS rates (77.5% v 91.8%; hazard ratio, 1.70; 95% CI, 1.03 to 2.79; P = .037). Among patients with high-risk tumors, those with Immunoscore-Low versus Immunoscore-High tumors also had significantly worse DFS (55.3% v 70.3%; hazard ratio, 1.65; 95% CI, 1.11 to 2.47; P = .013). Tumors that were low-risk/Immunoscore-Low had similar outcomes as did tumors that were high-risk/Immunoscore-High ( P = .174). Prognostication was significantly improved in multivariable models where Immunoscore was added to clinical risk parameters and limited biomarkers (likelihood ratio test P = .0003). CONCLUSION Immunoscore can refine patient prognosis beyond clinical risk group classification, suggesting its potential utility for adjuvant decision making.
Post-EMR for colorectal polyps, thermal ablation of defects reduces adenoma recurrence: A meta-analysis
Kandel, Pujan , Yadav, Deepesh , Dhungana, Santosh, Brahmbhatt, Bhaumik , Lukens, Frank , Bachuwa, Ghassan , Wallace, Michael B. , Raimondo, Massimo , Lukens, Frank J., Wallace, Michael B , Hussain, Murtaza Shabbir

Mayo Clinic

Endoscopy International Open | August 11, 2022 | Volume: 10 | Issue: 10 | Pages: E1399-E1405

10.1055/a-1922-7646 | PMID 36262518 Get It

Abstract Background and study aims Adenoma recurrence is one of the key limitations of endoscopic mucosal resection (EMR), which occurs in 15 % to 30 % of cases during first surveillance colonoscopy. The main hypothesis behind adenoma recurrence is leftover micro-adenomas at the margins of post-EMR defects. In this systematic review and meta-analysis, we evaluated the efficacy of snare tip soft coagulation (STSC) at the margins of mucosal defects to reduce adenoma recurrence and bleeding complications. Methods Electronic databases such as PubMed and the Cochrane library were used for systematic literature search. Studies with polyps only resected by piecemeal EMR and active treatment: with STSC, comparator: non-STSC were included. A random effects model was used to calculate the summary of risk ratio and 95 % confidence intervals. The main outcome of the study was to compare the effect of STSC versus non-STSC with respect to adenoma recurrence at first surveillance colonoscopy after thermal ablation of post-EMR defects. Results Five studies were included in the systematic review and meta-analysis. The total number patients who completed first surveillance colonoscopy (SC1) in the STSC group was 534 and in the non-STSC group was 514. The pooled adenoma recurrence rate was 6 % (37 of 534 cases) in the STSC arm and 22 % (115 of 514 cases) in the non-STSC arm, (odds ratio [OR] 0.26, 95 % confidence interval [CI], 0.16–0.41, P = 0.001). The pooled delayed post-EMR bleeding rate 19 % (67 of 343) in the STSC arm and 22 % (78 of 341) in the non-STSC arm (OR 0.82, 95 %CI, 0.57–1.18). Conclusions Thermal ablation of post-EMR defects significantly reduces adenoma recurrence at first surveillance colonoscopy.
Quality measures for the care of adult patients with obstructive sleep apnea: 2022 update after measure maintenance
Lloyd, Robin M. , Donald, Ryan, Gray, Diedra D., Lewin, Daniel , Revana, Amee , Schutte-Rodin, Sharon, Lloyd, Robin, Morgenthaler, Timothy I. , Trotti, Lynn Marie

Mayo Clinic

Journal of Clinical Sleep Medicine | August 11, 2022 | Volume: 18 | Issue: 11 | Pages: 2673-2680

10.5664/jcsm.10244 | PMID 36308029 Get It

Late‐onset mania in autopsy‐confirmed Lewy body disease: A rare symptom of prodromal dementia with Lewy bodies?
Koga, Shunsuke , Sekiya, Hiroaki , Martin, Nicholas B. , Dickson, Dennis W. , Koga, Shunsuke , Dickson, Dennis W , Sekiya, Hiroaki

Mayo Clinic

Bipolar Disorders | August 11, 2022 | Volume: 24 | Issue: 6 | Pages: 683-684

10.1111/bdi.13246 | PMID 35950910 Get It